TEVA shorts unwind as retail attention spikes

Three distinct signals on TEVA are pointing the same direction. Short positions are shrinking fast, options traders are leaning bullish, and retail attention just surged to its highest level in months.

Short sellers pulling back

Short interest stood at 29.3 million shares on October 19, down from 36.7 million on October 7. That is a decline of roughly 20% in under two weeks. The ORTEX short score has followed: it dropped from 50.8 on October 7 to 43.9 on October 19, the lowest reading in the visible history of the series.

Cost to borrow reflects the same picture. It fell to 0.46% on October 19, down 28% over the week and its lowest level in a month. Availability sits at 1,393%, meaning roughly 14 shares remain available to borrow for every one already lent out. The borrow market is loose. Short sellers exiting their positions are doing so without friction.

Options confirm the lean

The put-call ratio closed at 0.50 on October 19, 2.1 standard deviations below its 20-day mean of 0.55. That is close to the 52-week low of 0.44. The options market is leaning as call-heavy as it has been all year, a shift that started in the second half of September when the PCR was running at 0.59.

Retail attention jumps

Wikipedia views and ORTEX page traffic for Teva have spiked to 3.65 standard deviations above their 90-day average as of October 20. This is a measure of retail attention against Teva's own recent history, not a revenue signal. It captures an unusual burst of public interest in the stock at the same moment that positioning is shifting.

The company reports next on November 3. The stock is up about 6% over the past month and was trading at $41.31 on October 19. BlackRock added 27.9 million shares in the quarter to September 30, lifting its stake to 8.4% of shares outstanding.

What to watch

• November 3 earnings: the short unwind and bullish options skew set up a clean read on whether conviction holds into the print
• The put-call ratio's 52-week low of 0.44, whether it breaks lower as the date approaches
• Short interest in shares: at 29.3 million, any reversal back above 32 million would signal renewed bearish positioning

---

Data summary

• Short interest: 29.3M shares (Oct 19), down from 36.7M on Oct 7
• ORTEX short score: 43.9 (Oct 19), down from 50.8 on Oct 7
• Cost to borrow: 0.46%, down 28% week-on-week
• Borrow availability: 1,393%
• Put-call ratio: 0.50, 2.1 std dev below 20-day mean
• Retail attention z-score: 3.65 (Oct 20), Wikipedia + ORTEX traffic
• Next earnings: November 3, 2026